Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Scott

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
BMJ Open|August 9, 2020
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trialDagmar F Hernandez-Suarez, Kyle Melin, Frances Marin-Maldonado, et al.
Pharmacogenomics and Personalized Medicine|June 21, 2018
Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean populationDagmar F Hernandez-Suarez, Mariana R Botton, Stuart A Scott, et al.
Drug Metabolism and Personalized Therapy|February 7, 2018
Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapyDagmar F Hernandez-Suarez, Hector Núñez-Medina, Stuart A Scott, et al.
Vascular Medicine (London, England)|September 14, 2013
Warfarin pharmacogenetics: a controlled dose-response study in healthy subjectsDaniella L Kadian-Dodov, Sarina A van der Zee, Stuart A Scott, et al.
Clinical Pharmacology and Therapeutics|November 14, 2022
Prescriber Adoption of SLCO1B1 Genotype-Guided Simvastatin Clinical Decision Support in a Clinical Pharmacogenetics ProgramAniwaa Owusu Obeng, Stuart A Scott, Tom Kaszemacher, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2020
Recommendations for Clinical Warfarin Genotyping Allele Selection: A Report of the Association for Molecular Pathology and the College of American PathologistsVictoria M Pratt, Larisa H Cavallari, Andria L Del Tredici, et al.
Clinical and Translational Science|October 25, 2019
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working GroupKelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical PracticeTeresa T Ho, D Max Smith, Christina L Aquilante, et al.
JAMA Network Open|March 4, 2022
Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical TrialGirish N Nadkarni, Kezhen Fei, Michelle A Ramos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 22, 2016
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
BMJ Open|August 9, 2020
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trialDagmar F Hernandez-Suarez, Kyle Melin, Frances Marin-Maldonado, et al.
Pharmacogenomics and Personalized Medicine|June 21, 2018
Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean populationDagmar F Hernandez-Suarez, Mariana R Botton, Stuart A Scott, et al.
Drug Metabolism and Personalized Therapy|February 7, 2018
Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapyDagmar F Hernandez-Suarez, Hector Núñez-Medina, Stuart A Scott, et al.
Vascular Medicine (London, England)|September 14, 2013
Warfarin pharmacogenetics: a controlled dose-response study in healthy subjectsDaniella L Kadian-Dodov, Sarina A van der Zee, Stuart A Scott, et al.
Clinical Pharmacology and Therapeutics|November 14, 2022
Prescriber Adoption of SLCO1B1 Genotype-Guided Simvastatin Clinical Decision Support in a Clinical Pharmacogenetics ProgramAniwaa Owusu Obeng, Stuart A Scott, Tom Kaszemacher, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2020
Recommendations for Clinical Warfarin Genotyping Allele Selection: A Report of the Association for Molecular Pathology and the College of American PathologistsVictoria M Pratt, Larisa H Cavallari, Andria L Del Tredici, et al.
Clinical and Translational Science|October 25, 2019
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working GroupKelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical PracticeTeresa T Ho, D Max Smith, Christina L Aquilante, et al.
JAMA Network Open|March 4, 2022
Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical TrialGirish N Nadkarni, Kezhen Fei, Michelle A Ramos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 22, 2016
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, et al.
Pageof 15